Editorial
The Renal Frontier in TAVR

https://doi.org/10.1053/j.jvca.2017.02.030Get rights and content

References (33)

  • G.C. Kane et al.

    Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography

    J Am Coll Cardiol

    (2008)
  • M. Barbanti et al.

    Acute kidney injury with the RenalGuard System in patients undergoing transcatheter aortic valve replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation)

    JACC Cardiovasc Interv

    (2015)
  • M.B. Leon et al.

    Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery

    N Engl J Med

    (2010)
  • C.R. Smith et al.

    Transcatheter versus surgical aortic-valve replacement in high-risk patients

    N Engl J Med

    (2011)
  • R.A. Nishimura et al.

    2014 AHA/ACC Guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    J Am Coll Cardiol

    (2014)
  • C.S. Rihal et al.

    Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention

    Circulation

    (2002)
  • Cited by (4)

    • Impact of Renal Failure on Valvular Heart Disease

      2020, Textbook of Cardiorenal Medicine
    View full text